Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardinal sees no retail opposition to Bergen merger; regional antitrust issues not a concern.

This article was originally published in The Tan Sheet

Executive Summary

CARDINAL CLAIMS RETAIL CUSTOMER SUPPORT FOR BERGEN BRUNSWIG MERGER, Chief Operating Officer John Kane told the recent Bear Stearns health care conference in New York City. "We have gotten tremendously high customer acceptance and customer affidavit support" for the merger of Cardinal Health and Bergen Brunswig to create the largest drug wholesaler, Kane maintained. "I know the [Federal Trade Commission] is calling customers, and we are surprised that the response we've had is much higher than we thought it would be." Cardinal and Bergen announced the merger in August ("The Tan Sheet" Sept. 1, p. 9).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel